| # | Drug | Count |
|---|---|---|
| 0 | PANITUMUMAB | 591 |
| 1 | OXALIPLATIN | 375 |
| 2 | FLUOROURACIL | 362 |
| 3 | FLUOROURACIL CREAM, 0.5% | 362 |
| 4 | AFATINIB | 355 |
| 5 | CAPECITABINE | 305 |
| 6 | CETUXIMAB | 265 |
| 7 | TRASTUZUMAB | 187 |
| 8 | BEVACIZUMAB | 185 |
| 9 | ACETAMINOPHEN | 179 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LAZERTINIB | 69 | 0.0798 |
| 1 | DACOMITINIB | 58 | 0.0774 |
| 2 | SELUMETINIB | 96 | 0.0570 |
| 3 | AFATINIB | 355 | 0.0536 |
| 4 | ICHTHAMMOL OINTMENT | 2 | 0.0526 |
| 5 | AMIVANTAMAB-VMJW | 178 | 0.0498 |
| 6 | PEGFILGRASTIM-BMEZ | 24 | 0.0395 |
| 7 | PANITUMUMAB | 591 | 0.0367 |
| 8 | DROPERIDOL | 26 | 0.0155 |
| 9 | ERDAFITINIB | 18 | 0.0144 |
| # | Drug class | Count |
|---|---|---|
| 0 | Epidermal Growth Factor Receptor Antagonist [EPC] | 822 |
| 1 | Kinase Inhibitor [EPC] | 810 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 672 |
| 3 | Platinum-based Drug [EPC] | 596 |
| 4 | Corticosteroid [EPC] | 440 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 345 |
| 6 | Microtubule Inhibitor [EPC] | 281 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 266 |
| 8 | Benzodiazepine [EPC] | 197 |
| 9 | HER2/neu Receptor Antagonist [EPC] | 191 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Epidermal Growth Factor Receptor Antagonist [EPC] | 822 | 0.0174 |
| 1 | Cannabinoid [EPC] | 31 | 0.0038 |
| 2 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 24 | 0.0038 |
| 3 | Dopamine-2 Receptor Antagonist [EPC] | 26 | 0.0033 |
| 4 | Antiseptic [EPC] | 12 | 0.0027 |
| 5 | HER2/neu Receptor Antagonist [EPC] | 191 | 0.0026 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 672 | 0.0025 |
| 7 | Platinum-based Drug [EPC] | 596 | 0.0022 |
| 8 | Microtubule Inhibitor [EPC] | 281 | 0.0017 |
| 9 | Estrogen Receptor Antagonist [EPC] | 65 | 0.0016 |